tetano
Editor, Senior Moderator
Kidney Med
. 2021 Apr 17.
doi: 10.1016/j.xkme.2021.03.003. Online ahead of print.
Acute Kidney Injury and Advanced Kidney Disease in the COVID-19 Pandemic: Proceedings From a National Kidney Foundation Symposium
Jamie S Hirsch[SUP] 1 [/SUP], Talat Alp Ikizler[SUP] 2 [/SUP], Shuchita Sharma[SUP] 3 [/SUP], Azeem Mohammed[SUP] 4 [/SUP]
Affiliations
Abstract
The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented and historic public health crisis that continues to expand and evolve. The National Kidney Foundation (NKF) held a two-part CME live virtual symposium on July 16th and July 24[SUP]th[/SUP] 2020 to address the multiple challenges of COVID-19 in the context of advanced chronic kidney disease (CKD). Faculty addressed the pathophysiology, impact, risks, and management of COVID-19 as it relates to advanced kidney disease. Testing, risk mitigation, and inpatient and outpatient management were also addressed. This concise review addresses major findings of the symposium along with certain updates regarding vaccinations since then. These findings include: 1) Severe COVID-19 has been associated with acute kidney injury (AKI); 2) It is essential to prevent and actively manage AKI to decrease mortality in these critically ill patients; 3) Management of patients with advanced kidney disease should be geared towards minimizing their risk of exposure while making sure they are receiving adequate treatments. 4) Patients with kidney disease, especially ones in advanced stages, should be prioritized for vaccination.
. 2021 Apr 17.
doi: 10.1016/j.xkme.2021.03.003. Online ahead of print.
Acute Kidney Injury and Advanced Kidney Disease in the COVID-19 Pandemic: Proceedings From a National Kidney Foundation Symposium
Jamie S Hirsch[SUP] 1 [/SUP], Talat Alp Ikizler[SUP] 2 [/SUP], Shuchita Sharma[SUP] 3 [/SUP], Azeem Mohammed[SUP] 4 [/SUP]
Affiliations
- PMID: 33898966
- PMCID: PMC8052503
- DOI: 10.1016/j.xkme.2021.03.003
Abstract
The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented and historic public health crisis that continues to expand and evolve. The National Kidney Foundation (NKF) held a two-part CME live virtual symposium on July 16th and July 24[SUP]th[/SUP] 2020 to address the multiple challenges of COVID-19 in the context of advanced chronic kidney disease (CKD). Faculty addressed the pathophysiology, impact, risks, and management of COVID-19 as it relates to advanced kidney disease. Testing, risk mitigation, and inpatient and outpatient management were also addressed. This concise review addresses major findings of the symposium along with certain updates regarding vaccinations since then. These findings include: 1) Severe COVID-19 has been associated with acute kidney injury (AKI); 2) It is essential to prevent and actively manage AKI to decrease mortality in these critically ill patients; 3) Management of patients with advanced kidney disease should be geared towards minimizing their risk of exposure while making sure they are receiving adequate treatments. 4) Patients with kidney disease, especially ones in advanced stages, should be prioritized for vaccination.